A fund designed for investors seeking regular and sustainable income

APN’s AREIT Fund (“Fund”) is suited to long term investors seeking relatively high income (paid monthly) and some capital growth. The Fund invests in listed Australian Real Estate Investment Trusts (AREITS), providing investors with exposure to an underlying portfolio of high quality commercial property.

Income focused

The Fund currently yields 5.42%pa1. Income is derived from the rents received on the underlying portfolio of commercial property held by the AREITs.

 

Monthly distributions

The Fund pays monthly distributions into your nominated account. Or you can choose to reinvest each distribution. 

Fees

The Fund charges a management cost of
0.85% pa and buy/sell spreads of 0.25%.

100% liquid

You can apply for and redeem units on a daily basis3.

APN AREIT Fund is rated by

Request an 
APN AREIT Fund information pack

Your personal information is important to us. 
Please read our Privacy Collection Notice.

 

Running yield

as at 11 March 2022

5.42%pa1

APN AREIT Fund

Total return

4.62%pa2

over 5 years to 
28 February 2022

Monthly distributions

ARSN: 134 361 229   |   APIR: APN0008AU 

  1. Current running yield is calculated daily by dividing the annualised distribution rate by the latest entry unit price. Distributions may include a capital gains component. Distributions are not guaranteed and past performance is not an indicator of future returns.
  2. Returns after all fees and expenses. Assumes distributions are reinvested. Investors' tax rates are not taken into account when calculating returns. Past performance is not an indicator of future performance. 
  3. Under normal market conditions.

*The APN AREIT Fund aims to provide lower than market volatility compared with the S&P/ASX 300 AREIT Index over a 5-7 year time horizon.

This summary has been prepared by Dexus Asset Management Limited (DXAM) (ACN 080 674 479, AFSL No. 237500) for general information purposes only and whilst every care has been taken in relation to its accuracy, no warranty is given or implied as to the fairness, accuracy or completeness or correctness of the information. DXAM is a wholly owned subsidiary of Dexus (ASX ticker code: DXS). DXAM is the responsible entity and issuer of the products referred to in this summary, unless specified otherwise. The information provided in this material does not constitute financial product advice and does not purport to contain all relevant information necessary for making an investment decision. It is provided on the basis that the recipient will be responsible for making their own assessment of financial needs and will seek further independent advice about the investments as is considered appropriate. Past performance is not necessarily an indication of future performance. Returns shown are for retail investors, net of fees and costs and are annualised for periods greater than one year. Returns and values may rise and fall from one period to another. Investors’ tax rates are not taken into account when calculating returns. General risks apply to an investment in DXAM’s funds and must be considered before making an investment. In deciding whether to invest or continue to hold an investment in a particular fund, a person should read the relevant Product Disclosure Statement (PDS) for the fund in its entirety. DXAM recommends that a person obtain financial, legal and taxation advice before making any financial investment decision. Allotments or issues of securities will be made only on receipt of an application form attached to a copy of the relevant PDS. A copy of the PDS is available from Dexus Asset Management Limited, Level 30, 101 Collins Street, Melbourne, Victoria 3000 or by visiting www.apnres.com.au

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned for the APN AREIT Fund in June 2021) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

The Lonsec Rating (assigned April 2021 for the APN AREIT Fund)) presented in this document is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445. The Rating is a “class service” (as defined in the Financial Advisers Act 2008 (NZ)) or is limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial product(s). In New Zealand it must only be provided to “wholesale clients” (as defined in the Financial Advisers Act 2008 (NZ)). Past performance information is for illustrative purposes only and is not indicative of future performance. It is not a recommendation to purchase, sell or hold APN or APNFM product(s), and you should seek independent financial advice before investing in this product(s). The Rating is subject to change without notice and Lonsec assumes no obligation to update the relevant document(s) following publication. Lonsec receives a fee from the fund manager for researching the product(s) using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at: http://www.beyond.lonsec.com.au/intelligence/lonsec-ratings. 

The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Lower volatility

Because we select AREITs based on a disciplined investment approach proven over
20 years, we have been able to deliver returns with less risk than the market*.